Madeed Closes $400K Pre-Seed Round to Advance Preventive Health and Longevity

Riyadh, Saudi Arabia – Madeed, a Saudi platform specializing in preventive health and longevity, has successfully closed a $400,000 Pre-Seed funding round led by Vision Ventures, alongside Saudi investors including Mashhoor Al-Debyan, Mazen Al-Dharrab, and Abdullah Elias.

The capital will be invested in product development, expanding clinical and laboratory partnerships across the region, and launching the platform’s first member cohort with an initial focus on the Saudi market.

Madeed is building a comprehensive platform aimed at proactive disease prevention and health optimization. By leveraging advanced laboratory screenings that detect hundreds of conditions before symptoms appear, the platform identifies early risk factors to help members take preventive action.

Members gain access to comprehensive health services, including blood tests, advanced biomarkers, detailed health reports, and physician-reviewed insights covering areas such as metabolic health, hormonal balance, cardiovascular risks, and inflammation.

Additionally, Madeed provides personalized lifestyle, nutrition, and supplement protocols, including a daily custom supplement tailored to each member’s lab results, removing guesswork and supporting long-term health improvements.

Madeed was founded by Dr. Adam Al-Bataineh, co-founder of the US-based Span Health platform, which was later acquired by Eight Sleep.